W, F., M, M., BZ, L., L, B., EF, G., HM, K., . . . MB, B. (2022). Inpatient Zoledronic Acid and Integrated Orthopedic and Fracture Liaison Services Improve Osteoporosis Treatment Rates. The Journal of clinical endocrinology and metabolism, 108(1), 191. https://doi.org/10.1210/clinem/dgac508
Chicago Style (17th ed.) CitationW, Fan, et al. "Inpatient Zoledronic Acid and Integrated Orthopedic and Fracture Liaison Services Improve Osteoporosis Treatment Rates." The Journal of Clinical Endocrinology and Metabolism 108, no. 1 (2022): 191. https://doi.org/10.1210/clinem/dgac508.
MLA (9th ed.) CitationW, Fan, et al. "Inpatient Zoledronic Acid and Integrated Orthopedic and Fracture Liaison Services Improve Osteoporosis Treatment Rates." The Journal of Clinical Endocrinology and Metabolism, vol. 108, no. 1, 2022, p. 191, https://doi.org/10.1210/clinem/dgac508.